The estimated Net Worth of Capital Advisors Lp Southpo... is at least $21.4 Milhão dollars as of 4 May 2020. Capital Southpo owns over 80,000 units of Fennec Pharmaceuticals Inc stock worth over $21,446,146 and over the last 5 years Capital sold FENC stock worth over $0.
Capital has made over 1 trades of the Fennec Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Capital bought 80,000 units of FENC stock worth $500,000 on 4 May 2020.
The largest trade Capital's ever made was buying 80,000 units of Fennec Pharmaceuticals Inc stock on 4 May 2020 worth over $500,000. On average, Capital trades about 80,000 units every 0 days since 2020. As of 4 May 2020 Capital still owns at least 4,077,214 units of Fennec Pharmaceuticals Inc stock.
You can see the complete history of Capital Southpo stock trades at the bottom of the page.
Over the last 10 years, insiders at Fennec Pharmaceuticals Inc have traded over $13,607,192 worth of Fennec Pharmaceuticals Inc stock and bought 1,966,488 units worth $9,890,813 . The most active insiders traders include Management Pr, Llcmancheste..., Spacavazza Paolo Cavazza En..., eRosty Raykov. On average, Fennec Pharmaceuticals Inc executives and independent directors trade stock every 69 days with the average trade being worth of $442,734. The most recent stock trade was executed by Rosty Raykov on 31 August 2024, trading 2,431 units of FENC stock currently worth $13,419.
fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.
Fennec Pharmaceuticals Inc executives and other stock owners filed with the SEC include: